(19)
(11) EP 4 565 213 A1

(12)

(43) Date of publication:
11.06.2025 Bulletin 2025/24

(21) Application number: 23748998.4

(22) Date of filing: 26.07.2023
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/519(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/519; A61K 9/2054; A61K 9/2027; A61K 9/2059
(86) International application number:
PCT/EP2023/070782
(87) International publication number:
WO 2024/028193 (08.02.2024 Gazette 2024/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 03.08.2022 EP 22382753

(71) Applicant: Medichem, S.A.
08970 Sant Joan Despi (ES)

(72) Inventors:
  • FERNÁNDEZ GARROSA, Isabel
    05002 ÁVILA (ES)
  • NG CHOI, I-Teng Montserrat
    17005 GIRONA (ES)
  • DURÁN LÓPEZ, Ernesto
    08755 CASTELLBISBAL (ES)

(74) Representative: ZBM Patents - Zea, Barlocci & Markvardsen 
Rambla de Catalunya, 123
08008 Barcelona
08008 Barcelona (ES)

   


(54) STABLE ORAL PHARMACEUTICAL FORMULATION CONTAINING RUXOLITINIB HEMIFUMARATE